Biologic Videos

  1. Cytovance Biologics Capacity Update January 2025: Large Molecule Development 1/28/2025

    Join Rose Rhomberg, Senior Business Development Director, as she showcases Cytovance’s microbial and mammalian capabilities, along with our available manufacturing capacity.

  2. Catalent Capacity Update January 2025: Large Molecule Development 1/28/2025

    Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.

  3. Building A Strong Safety Culture In The Biopharmaceutical Industry 1/25/2025

    Explore how fostering a strong safety culture — rooted in accountability, collaboration, and proactive risk management — can drive operational excellence and long-term success in biopharmaceuticals.

  4. How To Prevent Protein Aggregation Through Stabilizers And Surfactants 1/13/2025

    Learn about protein aggregation mechanisms, the role of excipients in stabilization, and novel surfactants that prevent aggregation in therapeutic protein formulations in this webinar.

  5. Exploring New And Improved Analytical Methods For Traditional And Unique Modalities 1/2/2025

    Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

  6. How Standardized Extractables Data Support E&L Risk Assessment 12/19/2024

    Explore E&L evaluations, USP <665>, supplier-provided extractables data, and collaborative strategies to mitigate risks in Single-Use Systems for biopharmaceutical manufacturing processes.

  7. Evaluating USP 665 For Extractables Testing And Reducing Animal Testing For Biological Reactivity 12/19/2024

    Explore evolving compendial methods, USP <665>, and transitioning to cell-based assays for extractables, leachables, and biological reactivity in single-use pharmaceutical manufacturing.

  8. Challenges Using Multiple Single-Use Systems Functionality Versus Extractables And Leachables 12/19/2024

    Explore a risk assessment of extractables, evaluating single-use components, and addressing complexities in manufacturing processes, with a case study highlighting compatibility and patient safety concerns.

  9. Streamline Bioprocesses While Meeting The Demands Of Modern Cell Culture 12/13/2024

    Xcellerex™ X-platform bioreactors offer modular, user-friendly designs with optimized scalability, adaptable automation, and standardization, enhancing productivity in pilot and cGMP cell culture operations.

  10. Demonstrating Technical Excellence In Contract Manufacturing 12/10/2024

    Tech Talks explore ADC development innovations, including integrated supply chains, seamless pilot-to-GMP scale-ups, and advanced process analytical technology (PAT).